Massimiliano Missere

Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging

A. Pepe, Antonella Meloni, Marcello Capra et al. · Haematologica · 2010 · 145 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Cardiac and hepatic iron and ejection fraction in thalassemia major: Multicentre prospective comparison of combined Deferiprone and Deferoxamine therapy against Deferiprone or Deferoxamine Monotherapy

Alessia Pepe, Antonella Meloni, Giuseppe Rossi et al. · Journal of Cardiovascular Magnetic Resonance · 2013 · 138 citations · Full text

Medicine, Cardiology, Pharmacology +16

Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach

Alessia Pepe, Antonella Meloni, Giuseppe Rossi et al. · European Heart Journal - Cardiovascular Imaging · 2017 · 116 citations · Full text

Medicine, Cardiology, Radiology +17

National networking in rare diseases and reduction of cardiac burden in thalassemia major

Alessia Pepe, Laura Pistoia, Maria Rita Gamberini et al. · European Heart Journal · 2021 · 56 citations

Medicine, Cardiology, Radiology +17

Regional and global pancreatic <i>T</i>*₂ MRI for iron overload assessment in a large cohort of healthy subjects: Normal values and correlation with age and gender

Gennaro Restaino, Antonella Meloni, Vincenzo Positano et al. · Magnetic Resonance in Medicine · 2010 · 53 citations

Medicine, Radiology, Biomedical Imaging +12